NCT06133569 ReDirection - Self Help Program for Individuals with Sexual Interest in Children
| NCT ID | NCT06133569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Child Abuse Sexual |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-27 |
| Primary Completion | 2024-10-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-09-27 with a primary completion date of 2024-10-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse. Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?
Eligibility Criteria
Inclusion Criteria: * Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish * concern about sexual interest regarding children\*, * CSAM use past six month * Low to medium risk for committing child sexual abuse according to the SChiMRA scale Exclusion Criteria: \- Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06133569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Child Abuse Sexual. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06133569 currently recruiting?
Yes, NCT06133569 is actively recruiting participants. Contact the research team at christoffer.rahm@ki.se for enrollment information.
Where is the NCT06133569 trial being conducted?
This trial is being conducted at Klecany, Czechia, Helsinki, Finland, Hamburg, Germany, Bratislava, Slovakia and 2 additional locations.
Who is sponsoring the NCT06133569 clinical trial?
NCT06133569 is sponsored by Karolinska Institutet. The trial plans to enroll 60 participants.